Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options Due to FDA communications, Cellectar Biosciences will explore options for development of its cancer drug. Focus on isotopes for solid tumors.
Cancer-Focused Cellectar Biosciences Stock Trades Lower Despite Meeting Goal In Blood Cancer Study Cellectar Biosciences stock drops 19.2% following the release of CLOVER WaM study results. The pivotal study for iopofosine I 131 in relapsed/refractory Waldenstrom's macroglobulinemia showed an 80% overall response rate.
CLRB Stock Earnings: Cellectar Biosciences Misses EPS for Q1 2024 CLRB stock results show that Cellectar Biosciences missed analyst estimates for earnings per share the first quarter of 2024.
Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50% Reddit stock is a hot topic among traders on Wednesday after one analyst warns that RDDT could give up 50% of its gains.
Why Is Gamida Cell (GMDA) Stock Down 82% Today? Gamida Cell stock is falling on Wednesday with heavy trading of GMDA shares after the company announced plans to go private.
CLRB Stock Earnings: Cellectar Biosciences Beats EPS for Q4 2023 CLRB stock results show that Cellectar Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Earnings Scheduled For March 27, 2024 Companies Reporting Before The Bell • Local Bounti (
NYSE:LOCL ) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why Cellectar Biosciences reports positive Phase 1 trial results for iopofosine I 131 in head and neck squamous cell carcinoma, achieving 64% complete remission and 73% overall response rate. Roth Capital notes the drug's potential across various diseases, positioning CLRB as an attractive acquisition target.
Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today? Cellectar Biosciences Inc (
NASDAQ: CLRB ) announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a targeted radiotherapy candidate for the treatment of relapsed/refractory Waldenstrom's macroglobulinemia (WM) patients that have received at
Wells Fargo Is Warming Up to Enphase Energy (ENPH) Stock Enphase Energy stock is rising higher on Monday as investors react to a new upgrade and increased price target for ENPH from Wells Fargo.
Why Is Spirit AeroSystems (SPR) Stock Down 14% Today? Spirit AeroSystems stock is falling hard on Monday as investors in SPR react to one of the company's flights experiencing a mid-air blowout.
Why Is LumiraDx (LMDX) Stock Down 13% Today? LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today? Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
